BACKGROUND
microXpace was established in March 2022 and specializes in microbiome-based biotechnologies to improve animal health. Its innovations focus on leveraging natural immune responses to reduce infectious disease burdens in aquaculture, poultry, and pet animals, promoting sustainable practices in food production and animal care.
DESCRIPTION OF PRODUCTS / SERVICES / TECHNOLOGY
- ChickGalX: A feed additive boosting anti-alpha-Gal antibodies in poultry, enhancing disease resistance.
- AquaGalX: Similar alpha-Gal technology applied to aquaculture for pathogen resistance.
- GiardiX: Probiotic treatment for giardiosis, using modified bile salts to combat the parasite Giardia intestinalis.
- SalmonX: A feed-based solution that disrupts sea lice infestations in salmon farming.
These products utilize patented microbiome technologies to support health and reduce dependency on traditional medications.
ACHIEVEMENTS / COLLABORATIONS / HIGHLIGHTS
Collaborations
- Partnered with Lallemand Animal Nutrition to develop alpha-Gal-based technologies.
- Partnerships with INRAe (National Research Institute for Agriculture, Food and Environment, France); Centro Interdisciplinario para la Investigación Acuícola (INCAR, Chile); Nature Research Centre (NRC, Lithuania); University of Veterinary Medicine (vetmeduni, Austria)
Highlights
- Transition to product development phase for alpha-Gal technology (March 2024).
- Probiotic advancements targeting parasitic diseases.
COLLABORATIONS SOUGHT
- Research partnerships to expand microbial solutions into new markets.
- Licensing agreements for technology in non-poultry and aquaculture industries.
- Investors interested in scaling production and global distribution.